Natera, Inc.
Clinical trials sponsored by Natera, Inc., explained in plain language.
-
Blood test may spare some women from radiation after endometrial cancer surgery
Knowledge-focused Not yet recruitingThis study looks at whether a blood test that detects tumor DNA can help decide if women with early-stage endometrial cancer need radiation after surgery. About 1,010 women will be followed for two years. Those with a negative blood test may safely skip radiation, while others re…
Phase: NA • Sponsor: Natera, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Blood test may let some stomach cancer patients skip harsh chemo
Knowledge-focused Not yet recruitingThis study tests whether a personalized blood test (Signatera) can identify gastric cancer patients who, after surgery, have no detectable cancer DNA and can safely receive a milder immunotherapy (durvalumab) instead of standard chemotherapy. About 1000 adults with stage II-IVa g…
Phase: NA • Sponsor: Natera, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC